Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Non-Current Deferred Tax Liability: 2009-2013

Historic Non-Current Deferred Tax Liability for Avadel Pharmaceuticals (AVDL) over the last 4 years, with Dec 2013 value amounting to $2.8 million.

  • Avadel Pharmaceuticals' Non-Current Deferred Tax Liability fell 40.18% to $3.5 million in Q1 2016 from the same period last year, while for Mar 2016 it was $3.5 million, marking a year-over-year decrease of 40.18%. This contributed to the annual value of $2.8 million for FY2013, which is 80.14% down from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Non-Current Deferred Tax Liability of $2.8 million as of FY2013, which was down 80.14% from $14.1 million recorded in FY2012.
  • In the past 5 years, Avadel Pharmaceuticals' Non-Current Deferred Tax Liability registered a high of $14.1 million during FY2012, and its lowest value of -$440,000 during FY2010.
  • Over the past 2 years, Avadel Pharmaceuticals' median Non-Current Deferred Tax Liability value was $8.5 million (recorded in 2012), while the average stood at $8.5 million.
  • Data for Avadel Pharmaceuticals' Non-Current Deferred Tax Liability shows a maximum YoY crashed of 80.14% (in 2013) over the last 5 years.
  • Over the past 4 years, Avadel Pharmaceuticals' Non-Current Deferred Tax Liability (Yearly) stood at -$339,000 in 2009, then decreased by 29.79% to -$440,000 in 2010, then reached $14.1 million in 2012, then slumped by 80.14% to $2.8 million in 2013.